Received: 4 February 2022
Accepted: 15 July 2022
First Online: 23 July 2022
: All <i>S. enterica</i> sampling and whole genome sequencing are done for disease surveillance purposes as part of the CDC PulseNet program. Samples used in the study were subcultured bacterial isolates that had been archived in the routine course of clinical laboratory operations. The New Hampshire Public Health Laboratories protocol for bacterial disease surveillance utilizing whole genome sequencing does not include human subjects research and hence, no review or approval from Institutional Review Board (IRB) is needed. No patient specimens were used and patient protected health information was not collected. Therefore, informed consent was not required.
: Not applicable.
: The authors declare that they have no competing interests.